Vyome acquires MIT AI startup Oculo Health to launch AI psychiatrist targeting inflammation

Vyome Holdings, Inc

Acquired substantially all assets of Oculo, Inc., an MIT-launched AI startup.
New business unit to develop an AI psychiatrist for reducing systemic inflammation.
AI subcommittee formed with MIT alumni Krishna Gupta, Mohanjit Jolly, and Stash Pomichter.
Company remains fully funded through 2026 to progress core biotech assets.
Transaction will not affect Vyome's existing inflammation-focused biotech programs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.